Showing results (121-130 of 354) with videos related to
Sort By:
Pageof 36
Transplantation|June 14, 2000
Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: risk factors, incidence, progression, and managementJ C Hong, B D KahanThe Journal of Urology|March 1, 1996
En bloc transplantation of kidneys from pediatric donorsA J Amante, B D KahanTransplantation|March 27, 1996
Case report--sirolimus rescue therapy for refractory renal allograft rejectionJ W Slaton, B D KahanTransplantation|January 1, 1991
Sequential determinations of serum interleukin 6 levels as an immunodiagnostic tool to differentiate rejection from nephrotoxicity in renal allograft recipientsN Yoshimura, T Oka, B D KahanTransplantation Proceedings|June 23, 2011
New-onset diabetes after renal transplantation: diagnosis, incidence, risk factors, impact on outcomes, and novel implicationsZ Kaposztas, E Gyurus, B D KahanTransplantation Proceedings|November 23, 2006
Use of sirolimus to facilitate steroid withdrawal from a cyclosporine regimenB D Kahan, J Podbielski, L SchoenbergTransplantation Proceedings|July 1, 2008
The impact of conversion from mycophenolate mofetil to mycophenolate sodium among renal transplant recipients on a sirolimus-based regimenB D Kahan, J Podbielski, B ChildsArchives of Surgery (Chicago, Ill. : 1960)|December 1, 1992
Immunotherapy with a tumor-infiltrating lymphocyte clone, soluble antigen, and cyclophosphamideH Komichi, S Smith, B D KahanTransplantation Proceedings|June 23, 2011
Sirolimus therapy predisposes to new-onset diabetes mellitus after renal transplantation: a long-term analysis of various treatment regimensE Gyurus, Z Kaposztas, B D KahanTransplantation|December 1, 1987
The role of class I and class II MHC antigens in the rejection of vascularized heart allografts in miceS M Stepkowski, A Raza-Ahmad, W R DuncanPageof 36